Schering-Plough to head the league table after Intervet buy?

On Friday, Animal Pharm reporter Max Thomas attended a presentation by Organon about its imminent minority IPO.

And when he sat down today to finish writing up the story, it was already obsolete!

Early this morning, Organon's parent Akzo Nobel announced it was selling the whole enterprise to Schering-Plough.

This may, or may not, catapault Schering-Plough to the top of the animal health industry league table, depending on which set of figures you put your faith in. It's probably too early to be sure.

But one thing IS sure, they're going be giving Pfizer and Merial a run for their money.

So long. Farewell. Auf Wiedersehn...

Well, it's happened.

Animal Pharm's editor has flown the coop. Ben Deighton, a colleague for several years now, has decided to move over to AFX Newswire and try his hand at mainstream financial journalism.

Ben made a significant contribution to Animal Pharm and took over from me as editor just a year ago.

We'll all miss having him around. The office will be a great deal quieter!

Watch this space for the first news of his replacement. Interviewing begins this week.

Incidentally, if you think you might be a suitable candidate, you can find more information about the role at: http://www.animalpharmnews.com/careers.shtml